Frankfurt - Delayed Quote EUR

Filament Health Corp. (7QS.F)

Compare
0.0175
0.0000
(0.00%)
At close: January 28 at 8:11:33 AM GMT+1
Currency in CAD All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
Total Revenue
2,157.6650
2,130.9740
364.5000
--
Cost of Revenue
--
--
--
913.6470
Gross Profit
--
--
364.5000
-913.6470
Operating Expense
5,855.0800
7,050.6180
5,879.0480
6,355.2760
Operating Income
-3,697.4150
-4,919.6440
-5,514.5480
-7,268.9230
Net Non Operating Interest Income Expense
-339.4040
-374.5670
-184.6700
-40.0830
Other Income Expense
-113.2510
-27.8210
-10,837.7850
-1,982.3490
Pretax Income
-4,150.0700
-5,322.0320
-16,537.0030
-9,291.3550
Tax Provision
--
--
-70.5380
-37.7480
Net Income Common Stockholders
-4,150.0700
-5,322.0320
-16,466.4650
-9,253.6070
Diluted NI Available to Com Stockholders
-4,150.0700
-5,322.0320
-16,466.4650
-9,253.6070
Basic EPS
-0.02
-0.03
-0.10
-0.06
Diluted EPS
-0.02
-0.03
-0.10
-0.06
Basic Average Shares
228,422.1380
187,682.0170
169,646.8340
147,037.6950
Diluted Average Shares
228,422.1380
187,682.0170
169,646.8340
147,037.6950
Total Expenses
5,855.0800
7,050.6180
5,879.0480
7,268.9230
Net Income from Continuing & Discontinued Operation
-4,150.0700
-5,322.0320
-16,466.4650
-9,253.6070
Normalized Income
-4,150.0700
-5,322.0320
-5,661.3184
-7,260.6379
Interest Expense
339.4040
374.5670
184.6700
40.0830
Net Interest Income
-339.4040
-374.5670
-184.6700
-40.0830
EBIT
-3,810.6660
-4,947.4650
-16,352.3330
-9,251.2720
EBITDA
-3,596.5120
-4,738.6680
-16,151.6880
-9,079.1820
Reconciled Cost of Revenue
--
--
--
913.6470
Reconciled Depreciation
214.1540
208.7970
200.6450
172.0900
Net Income from Continuing Operation Net Minority Interest
-4,150.0700
-5,322.0320
-16,466.4650
-9,253.6070
Total Unusual Items Excluding Goodwill
--
--
-10,851.4330
-2,001.0990
Total Unusual Items
--
--
-10,851.4330
-2,001.0990
Normalized EBITDA
-3,596.5120
-4,738.6680
-5,300.2550
-7,078.0830
Tax Rate for Calcs
--
--
0.0000
0.0000
Tax Effect of Unusual Items
--
--
-46.2864
-8.1299
12/31/2021 - 10/15/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers